论文部分内容阅读
英国科学家近期开发出一种治疗丙型肝炎的新型口服药物——三氟甲基衍生物。它可以激活免疫系统中的Toll样受体7(TLR7),进而产生抑制病毒复制的蛋白质。目前,口服药物中最有效的TLR7激活剂大多
British scientists have recently developed a new type of oral drug for the treatment of hepatitis C - trifluoromethyl derivatives. It activates Toll-like receptor 7 (TLR7) in the immune system, resulting in a protein that inhibits viral replication. At present, most of the most effective TLR7 activators in oral medicines are